All lobbying clients

Ira Watchdog

Ira Watchdog has been represented by 1 lobbying firm in 7 filings since 2025, with $140,000 in reported spending; the newest was posted October 20, 2026.

As filed: IRA WATCHDOG. Client based in District of Columbia.

Coalition analyzing impact of Medicare Drug Price Negotiation on patients.

$140,000 Reported spend

7 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (68339), filed by the registrant listed below.

Who filed for this client 1

DLA Piper LLP (US) $140,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $80,000 3 filings
2025 $60,000 4 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 7 total

Q3 report

DLA Piper LLP (US)

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2026

View → Q2 report

DLA Piper LLP (US)

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 20, 2026

View → Q1 report

DLA Piper LLP (US)

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 20, 2026

View → Q4 report

DLA Piper LLP (US)

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $20,000 income · posted Jan 20, 2026

View → Q3 report

DLA Piper LLP (US)

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 20, 2025

View → Q2 report

DLA Piper LLP (US)

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Aug 13, 2025

View → Registration

DLA Piper LLP (US)

2nd Quarter 2025 (Apr 1 - June 30) · posted Aug 11, 2025

View →

Foreign entities disclosed 1

ASTRAZENECA PLC United Kingdom named on 1 filing · highest disclosed ownership 0% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Affiliated organisations 4

ASTRAZENECA PHARMACEUTICALS LP United States of America named on 1 filing
BRISTOL-MYERS SQUIBB COMPANY United States of America named on 1 filing
ELI LILLY AND COMPANY United States of America named on 1 filing
MERCK & CO., INC. United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.